MAIA Biotechnology, Inc.
MAIA · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $54,541 | $42,376 | $51,793 |
| - Cash | $10,892 | $10,145 | $10,863 | $9,601 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $44,396 | $31,513 | $42,192 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $458 | -$5,166 | -$5,425 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$8,903 | -$5,347 | -$4,517 | -$3,572 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.27 | -0.18 | -0.16 | -0.14 |
| % Growth | -50% | -12.5% | -14.3% | – |
| Operating Cash Flow | -$3,487 | -$4,135 | -$4,202 | -$3,908 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3,487 | -$4,135 | -$4,202 | -$3,908 |